Gordon, K.; Papp, K.; Gooderham, M.; Morita, A.; Foley, P.; Tha?i, D.; Kundu, S.; Kisa, R.; Wei, L.; Banergee, S. BMS-986165, an Oral, Selective Tyrosine Kinase 2 (TYK2) Inhibitor: Evaluation of Changes in Laboratory Parameters in Response to Treatment in a Phase 2 Trial in Psoriasis Patients. J of Skin 2020, 4, s28.